A few developments in the marijuana industry have kept shorts of cannabis stocks at bay, a new report from research firm S3 Analytics stated.

On Wednesday (November 20), the firm published a study indicating short sellers of the marijuana public market were down US$272 million during the trading session, for the top 20 cannabis stocks tracked by S3 Analytics.


The report noted that short exposure for cannabis is up 16 percent so far this year for a total of US$389 million.

“Short selling is fairly concentrated to a handful of names, with only six stocks topping US$100 million of short interest,” the report said. It was authored by Ihor Dusaniwsky, managing director of predictive analytics at S3 Partners — the parent firm of S3 Analytics.

The researcher identified that the short market has seen a year-long trend of net short selling for the top 20 cannabis names and has so far reached US$1.41 billion.

“The increased short selling was needed to maintain overall short exposure in the sector as sector-wide price weakness decreased the notional value of the total short positions by just over US$1 billion,” Dusaniwsky wrote.

According to the report, a combination of the positive vote for the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act) by the House Judiciary Committee helped cause the drop for shorts.

Alongside the vote, the following developments also caused the short dip:

  • Canopy Growth (NYSE:CGC,TSX:WEED) obtaining a rate raise from the wealth management division of Bank of America (NYSE:BAC);
  • Cronos Group (NASDAQ:CRON,TSX:CRON) investee Altria Group (NYSE:MO) upping its stake in the marijuana company to keep a 45 percent ownership of Cronos; and
  • The Green Organic Dutchman (TSX:TGOD,OTCQX:TGODF) announcing distribution for its products in Alberta, Manitoba and Nova Scotia.

Dusaniwsky said the top shorted stocks from the leading pack of 20 were Cronos, Canopy Growth and GW Pharma (NYSE:GWPH).

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less